ClinicalTrials.Veeva

Menu

Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)

U

Universidade do Porto

Status

Completed

Conditions

Intracranial Pressure
Critically Ill
Cerebral Perfusion Pressure
Intracerebral Hemorrhage
Prognostic

Treatments

Diagnostic Test: Multimodal Neuromonitoring

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

Full description

Retrospective observational study based on analyzing the first 48 hours of the multimodal neuromonitoring signal, from spontaneous ICH patients, whose treatment includes invasive intraparenchymal neuromonitoring, treated from January 2015 to September 2021 in a tertiary hospital.

Enrollment

65 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Spontaneous Intracerebral Hemorrhage
  • ICU admission
  • Need of Sedation and Ventilatory Support
  • Need of Intracerebral Neuromonitoring

Exclusion criteria

  • Etiology for Intracerebral hemorrhage such as tumor, vascular malformation, ischemic transformation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems